Benefit of tamoxifen in estrogen receptor positive DCIS of the breast. - Wikidata - awgldk - TriplyDB

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

http://www.wikidata.org/entity/Q33972903

about

miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN.MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.

P2860

Q37732950-C579DCF1-CBDB-4D58-9289-CA18BC2535A5 Q47138409-D858E6B6-A764-48F3-867F-E0EBCF171A7B

P2860

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

http://www.wikidata.org/entity/Q33972903

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@ast

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@en

type

label

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@ast

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@en

prefLabel

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@ast

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@en

P1433

Q33972903-D4D3A337-979C-4DEC-A487-127E02446D3A

P1476

Q33972903-3181B1F7-1A89-4AD3-94F9-DC897852432D

P2093

Q33972903-4E18657D-FC4A-404B-9BEC-3D66155B4537

Q33972903-E73E946F-AA54-435E-85F6-85F102EE6D08

P2860

Q33972903-11BB228C-6CBF-4265-B416-D28DC501C17D

Q33972903-2D5774A0-A0CE-4399-94E9-A6D5DB9D75D4

Q33972903-6A971A82-C011-425C-8F84-9B9F8EF1CFF0

Q33972903-7A484403-3A33-4FD4-B5DF-FF5A62DD6773

Q33972903-D106A222-1455-4AA1-BE2E-A42413D609E9

Q33972903-D5B51C10-F6A2-499D-B64B-D32A37EA210B

P304

Q33972903-5E768DAE-DABD-4853-B0E7-CCE45FD364C9

P31

Q33972903-2C693C8E-2FCA-40CF-95B3-34669A3F9F79

P356

Q33972903-7735CCCD-5F8B-4CEF-8121-6FA29821894E

P433

Q33972903-F2D00B4C-288C-4F8C-BD34-5EC810B69182

P478

Q33972903-23BFEF00-B321-465D-89C6-43FE04393221

P577

Q33972903-5528FC1F-7898-481C-A885-4775676B429E

P698

Q33972903-155AA38A-1374-44F0-AC0C-FA0AC94AE815

P932

Q33972903-CD03B005-37A3-42F9-AF7B-702F17700AB3

P356

J.ISSN.2227-684X.2012.04.03

P1433

P1476

Benefit of tamoxifen in estrogen receptor positive DCIS of the breast.

@en

P2093

Petrelli Fausto

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.

Network meta-analysis of margin threshold for women with ductal carcinoma in situ

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.

P304

3-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2227-684X.2012.04.03

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25083418

http://www.w3.org/2001/XMLSchema#string

P932

4115708

http://www.w3.org/2001/XMLSchema#string